Tanya B. Dorff, MD

Tanya B. Dorff, MD, is associate professor of medical oncology and therapeutics research and section chief of the Genitourinary Disease Program at City of Hope, a top-ranked National Cancer Institute–designated Comprehensive Cancer Center in Duarte, CA. She completed her MD at the University of California, Los Angeles, where she was inducted into the national medical honor society Alpha Omega Alpha. She then went on to complete her residency at Mount Sinai Medical Center in New York, NY, and a fellowship in hematology-oncology at LAC + USC Medical Center in Los Angeles, CA. After nearly 10 years on faculty at the Keck School of Medicine of the University of Southern California, she moved on to City of Hope to develop a novel immunotherapy research program. 

Dr Dorff has authored or coauthored nearly 150 publications, is the principal investigator for several grant-funded and investigator-initiated studies, and participates as a key investigator in national and international clinical trials. Her translational research includes leading a phase 1 first-in-human study of chimeric antigen receptor T-cell therapy for prostate cancer, as well as studies interrogating genomic and immune differences in diverse populations of patients with prostate cancer. 

She is cochair of prostate cancer for the SWOG Genitourinary Cancer Committee and is leading efforts surrounding diversity, equity, and inclusion for that group. Dr Dorff is also a member of the National Comprehensive Cancer Network Prostate Cancer Guidelines Panel.